Cite
APA Citation
Cahn, A., Hamblin, J., Begg, M., Wilson, R., Dunsire, L., Sriskantharajah, S., Montembault, M., Leemereise, C., Galinanes-Garcia, L., Watz, H., Kirsten, A., Fuhr, R., & Hessel, E. (n.d.). safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD. Pulmonary pharmacology & therapeutics, 46, 69–77. http://access.bl.uk/ark:/81055/vdc_100066564023.0x000023